{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:35:49Z","timestamp":1785818149662,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015050","name":"Sociedad Espa\u00f1ola de Epilepsia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019582","name":"Soci\u00e9t\u00e9 d\u2019Imagerie G\u00e9nito Urinaire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013183","name":"Swine Innovation Porc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1902A"],"award-info":[{"award-number":["01GM1902A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["NV18-07-00283"],"award-info":[{"award-number":["NV18-07-00283"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005630","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005971","name":"Deutsche Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008979","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Endocrinologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008979","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmg.2021.104404","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T12:33:50Z","timestamp":1639053230000},"page":"104404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Management of growth failure and other endocrine aspects in patients with Noonan syndrome across Europe: A sub-analysis of a European clinical practice survey"],"prefix":"10.1016","volume":"65","author":[{"given":"Thomas","family":"Edouard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingegerd","family":"\u00d6stman-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-6279","authenticated-orcid":false,"given":"Eduardo","family":"Ortega Castell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Burkitt-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixto","family":"Garc\u00eda-Mi\u00f1a\u00far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2316-3334","authenticated-orcid":false,"given":"Guftar","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-5375","authenticated-orcid":false,"given":"Jan","family":"Lebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmg.2021.104404_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.1991.tb11880.x","article-title":"Noonan's syndrome: abnormalities of the growth hormone\/IGF-I axis and the response to treatment with human biosynthetic growth hormone","volume":"80","author":"Ahmed","year":"1991","journal-title":"Acta Paediatr. Scand."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-11-0092","article-title":"Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study","volume":"165","author":"Ankarberg-Lindgren","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104404_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajmg.a.38086","article-title":"Constitutional bone impairment in Noonan syndrome","volume":"173","author":"Baldassarre","year":"2017","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000479107","article-title":"Occurrence of cranial neoplasms in pediatric patients with noonan syndrome receiving growth hormone: is screening with brain MRI prior to initiation of growth hormone indicated?","volume":"88","author":"Bangalore Krishna","year":"2017","journal-title":"Hormone Res. Paediatr."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104404_bib5","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmg.2021.104404_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104404_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-15-0922","article-title":"Growth patterns of patients with Noonan syndrome: correlation with age and genotype","volume":"174","author":"Cessans","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104404_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2012.04.003","article-title":"Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?","volume":"106","author":"Choudhry","year":"2012","journal-title":"Mol. Genet. Metabol."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib9","first-page":"2291","article-title":"The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome","volume":"81","author":"Cotterill","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ejmg.2021.104404_bib10","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1073\/pnas.1119803109","article-title":"Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature","volume":"109","author":"De Rocca Serra-Nedelec","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104404_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1651-2227.1997.tb15175.x","article-title":"Growth hormone therapy in pre-pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome","volume":"86","author":"De Schepper","year":"1997","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ejmg.2021.104404_bib12","doi-asserted-by":"crossref","first-page":"116170","DOI":"10.1016\/j.bone.2021.116170","article-title":"Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels","volume":"153","author":"Delagrange","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.ejmg.2021.104404_bib13","first-page":"104371","article-title":"European Medical Education Initiative on Noonan syndrome: a clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe","author":"Garcia-Minaur","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104404_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000371635","article-title":"The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review","volume":"83","author":"Giacomozzi","year":"2015","journal-title":"Hormone Res. Paediatr."},{"issue":"8","key":"10.1016\/j.ejmg.2021.104404_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1507\/endocrj.EJ19-0371","article-title":"Long-term efficacy and safety of two doses of Norditropin((R)) (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients","volume":"67","author":"Horikawa","year":"2020","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib16","doi-asserted-by":"crossref","first-page":"103617","DOI":"10.1016\/j.ejmg.2019.01.007","article-title":"Oligo-astrocytoma in LZTR1-related noonan syndrome","volume":"63","author":"Jacquinet","year":"2020","journal-title":"Eur. J. Med. Genet."},{"issue":"8","key":"10.1016\/j.ejmg.2021.104404_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104404_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/adc.84.5.440","article-title":"Short stature in Noonan syndrome: response to growth hormone therapy","volume":"84","author":"Kirk","year":"2001","journal-title":"Arch. Dis. Child."},{"issue":"8","key":"10.1016\/j.ejmg.2021.104404_bib19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2015.75","article-title":"Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes","volume":"112","author":"Kratz","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1687-9856-2012-15","article-title":"Effect of 4 years of growth hormone therapy in children with noonan syndrome in the American norditropin studies: web-enabled research (ANSWER) program(R) registry","author":"Lee","year":"2012","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jc.2005-0983","article-title":"Noonan syndrome: relationships between genotype, growth, and growth factors","volume":"91","author":"Limal","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104404_bib22","first-page":"1953","article-title":"Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up","volume":"86","author":"MacFarlane","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ejmg.2021.104404_bib23","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/ajmg.a.35519","article-title":"Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS\/MAPK pathway","volume":"158A","author":"Malaquias","year":"2012","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104404_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000500264","article-title":"Impact of growth hormone therapy on adult height in patients with PTPN11 mutations related to noonan syndrome","volume":"91","author":"Malaquias","year":"2019","journal-title":"Hormone Res. Paediatr."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.a.37379","article-title":"Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy","volume":"170A","author":"McWilliams","year":"2016","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-18-0582","article-title":"Noonan syndrome males display Sertoli cell-specific primary testicular insufficiency","volume":"179","author":"Moniez","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"3\u20134","key":"10.1016\/j.ejmg.2021.104404_bib27","first-page":"110","article-title":"Effects of growth hormone treatment on left ventricular dimensions in children with Noonan's syndrome","volume":"56","author":"Noordam","year":"2001","journal-title":"Horm. Res."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104404_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-08-0413","article-title":"Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11","volume":"159","author":"Noordam","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1515\/JPEM.2002.15.1.81","article-title":"Bone mineral density and body composition in Noonan's syndrome: effects of growth hormone treatment","volume":"15","author":"Noordam","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.2001.01188.x","article-title":"Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment","volume":"54","author":"Noordam","year":"2001","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104404_bib31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1651-2227.2005.tb02081.x","article-title":"Improved final height with long-term growth hormone treatment in Noonan syndrome","volume":"94","author":"Osio","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ejmg.2021.104404_bib32","series-title":"Growth Hormone Therapy in Pediatrics \u2013 20 Years of KIGS","first-page":"347","article-title":"Short stature in noonan syndrome: results of growth hormone treatment in KIGS","author":"Otten","year":"2007"},{"issue":"7","key":"10.1016\/j.ejmg.2021.104404_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104404_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajmg.a.35290","article-title":"Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies","volume":"158A","author":"Quaio","year":"2012","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104404_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/JPEM.2008.21.3.267","article-title":"Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database","volume":"21","author":"Raaijmakers","year":"2008","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104404_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00441408","article-title":"Noonan syndrome: growth and clinical manifestations in 144 cases","volume":"148","author":"Ranke","year":"1988","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000498859","article-title":"Treatment with growth hormone in noonan syndrome observed during 25 Years of KIGS: near adult height and outcome prediction","volume":"91","author":"Ranke","year":"2019","journal-title":"Hormone Res. Paediatr."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib38","doi-asserted-by":"crossref","first-page":"e1619","DOI":"10.1542\/peds.2013-3607","article-title":"Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT","volume":"134","author":"Reus","year":"2014","journal-title":"Pediatrics"},{"issue":"9863","key":"10.1016\/j.ejmg.2021.104404_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000512429","article-title":"Long-term effectiveness and safety of childhood growth hormone treatment in noonan syndrome","volume":"93","author":"Rohrer","year":"2020","journal-title":"Hormone Res. Paediatr."},{"issue":"5 Pt 2","key":"10.1016\/j.ejmg.2021.104404_bib41","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0022-3476(96)70005-7","article-title":"Growth hormone treatment in noonan syndrome: the national cooperative growth study experience","volume":"128","author":"Romano","year":"1996","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.ejmg.2021.104404_bib42","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1210\/jc.2008-2094","article-title":"Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone","volume":"94","author":"Romano","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104404_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","article-title":"A clinical study of Noonan syndrome","volume":"67","author":"Sharland","year":"1992","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104404_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: a long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104404_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-0004.2010.01619.x","article-title":"Bone resorption in syndromes of the Ras\/MAPK pathway","volume":"80","author":"Stevenson","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2021.104404_bib46","doi-asserted-by":"crossref","DOI":"10.1210\/er.2017-00232","article-title":"The Rasopathy family: consequences of germline activation of the RAS\/MAPK pathway","author":"Tajan","year":"2018","journal-title":"Endocr. Rev."},{"issue":"13","key":"10.1016\/j.ejmg.2021.104404_bib47","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/hmg\/ddy133","article-title":"Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth","volume":"27","author":"Tajan","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.ejmg.2021.104404_bib48","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/ajmg.a.37260","article-title":"Response to long-term growth hormone therapy in patients affected by RASopathies and growth hormone deficiency: patterns of growth, puberty and final height data","volume":"167A","author":"Tamburrino","year":"2015","journal-title":"Am. J. Med. Genet."},{"issue":"7","key":"10.1016\/j.ejmg.2021.104404_bib49","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2169\/internalmedicine.31.908","article-title":"Noonan syndrome presenting growth hormone neurosecretory dysfunction","volume":"31","author":"Tanaka","year":"1992","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104404_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","article-title":"Noonan syndrome and clinically related disorders","volume":"25","author":"Tartaglia","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104404_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-835368","article-title":"Acromegaly and heart failure: revisions of the growth hormone\/insulin-like growth factor axis and its relation to the cardiovascular system","volume":"4","author":"Twickler","year":"2004","journal-title":"Semin. Vasc. Med."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104404_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","article-title":"Diagnosis and management of Silver-Russell syndrome: first international consensus statement","volume":"13","author":"Wakeling","year":"2017","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:08Z","timestamp":1761709928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221002706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1769721221002706"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104404","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of growth failure and other endocrine aspects in patients with Noonan syndrome across Europe: A sub-analysis of a European clinical practice survey","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104404"}}